The Lancet HaematologyVolume 8, Issue 10, October 2021, Pages e681-e683CommentAntibody response after third BNT162b2 dose in recipients of allogeneic HSCTAuthor links open overlay panelRabah Redjoul a, Anne Le Bouter b, Vincent Parinet a, Slim Fourati b c, Sébastien Maury a cShow moreShareCitehttps://doi.org/10.1016/S2352-3026(21)00274-XGet rights and contentPrevious article in issueNext article in issueRecommended articlesCited by (0)View Abstract© 2021 Elsevier Ltd. All rights reserved.